CVS Health Corp. buy Barclays PLC
Summary
This prediction ended on 11.10.25 with a price of €67.97. The BUY prediction by Barclays_PLC finished with a performance of 10.54%. Barclays_PLC has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. A total of €1.25 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -0.695% | -0.695% | 10.960% |
| iShares Core DAX® | -5.868% | -2.496% | 2.292% |
| iShares Nasdaq 100 | 1.660% | 3.513% | 13.191% |
| iShares Nikkei 225® | -6.126% | 2.136% | 27.665% |
| iShares S&P 500 | 0.504% | 2.045% | 9.817% |
Comments by Barclays_PLC for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.